Jeevan Scientific Technology Ltd is Rated Hold

Understanding the Current Rating

The 'Hold' rating assigned to Jeevan Scientific Technology Ltd indicates a balanced view of the stock’s prospects. It suggests that investors should maintain their current positions rather than aggressively buying or selling. This rating is based on a comprehensive evaluation of four key parameters: Quality, Valuation, Financial Trend, and Technicals. Each of these factors contributes to the overall assessment of the stock’s potential risk and reward profile.

Quality Assessment

As of 28 July 2026, the company’s quality grade is considered below average. This is primarily due to weak long-term fundamental strength, with a compound annual growth rate (CAGR) of operating profits declining by -25.88% over the past five years. Additionally, the average Return on Equity (ROE) stands at a modest 4.78%, indicating limited profitability relative to shareholders’ funds. Such figures highlight challenges in generating consistent earnings growth and efficient capital utilisation, which weigh on the company’s quality score.

Valuation Perspective

Despite the quality concerns, Jeevan Scientific Technology Ltd’s valuation grade is attractive. The stock trades at a discount relative to its peers, supported by a Return on Capital Employed (ROCE) of 3.8% and an enterprise value to capital employed ratio of 2. This valuation suggests that the market currently prices the company conservatively, potentially offering value for investors willing to accept the associated risks. The attractive valuation is a key factor supporting the 'Hold' rating, as it balances the weaker quality metrics.

Financial Trend and Recent Performance

The company’s financial trend is rated outstanding, reflecting strong recent operational results. As of 28 July 2026, Jeevan Scientific Technology Ltd has demonstrated robust growth in net sales, increasing by 111.63%, and declared positive results for two consecutive quarters. Quarterly Profit Before Tax (PBT) excluding other income reached ₹2.27 crores, growing at an impressive 184.07%. Cash and cash equivalents have also peaked at ₹9.51 crores, while net sales for the quarter hit a record ₹21.29 crores. These figures indicate a significant turnaround in the company’s short-term financial health, which supports the current rating.

Technical Analysis

The technical grade for the stock is mildly bullish. Market performance over the past year has been strong, with the stock delivering a 96.03% return, substantially outperforming the BSE500 index’s 0.88% return over the same period. Shorter-term price movements show mixed trends, with a 1-day gain of 1.91% and a 1-week rise of 8.28%, offset by modest declines over one and three months (-3.68% and -2.99%, respectively). The six-month and year-to-date returns remain positive at +30.19% and +20.15%. This technical momentum, combined with attractive valuation, supports a cautious but optimistic stance.

Market Capitalisation and Shareholding

Jeevan Scientific Technology Ltd is classified as a microcap company within the Healthcare Services sector. The majority of its shares are held by non-institutional investors, which can imply higher volatility and less analyst coverage compared to larger, institutionally backed firms. Investors should consider this factor when evaluating liquidity and potential price swings.

Implications for Investors

The 'Hold' rating reflects a nuanced view of Jeevan Scientific Technology Ltd. While the company faces challenges in long-term profitability and fundamental strength, its recent financial performance and attractive valuation provide a compelling case for maintaining current holdings. Investors should monitor the company’s ability to sustain sales growth and improve profitability metrics over time. The mildly bullish technical outlook suggests potential for further gains, but caution is warranted given the below-average quality grade.

Summary of Key Metrics as of 28 July 2026

• Operating Profit CAGR (5 years): -25.88%
• Average Return on Equity: 4.78%
• Net Sales Growth: 111.63%
• Quarterly PBT (excl. other income): ₹2.27 crores (growth of 184.07%)
• Cash and Cash Equivalents (Half Year): ₹9.51 crores
• Return on Capital Employed: 3.8%
• Enterprise Value to Capital Employed: 2
• 1-Year Stock Return: +96.03%
• BSE500 1-Year Return Benchmark: +0.88%

Contextualising the Rating

Investors should understand that the 'Hold' rating is not a call to exit the stock but rather an indication to maintain current positions while observing how the company navigates its challenges. The attractive valuation and recent financial improvements offer potential upside, but the weak quality metrics and historical profit declines suggest caution. This balanced outlook is typical for microcap stocks in the healthcare services sector, where volatility and growth prospects often coexist.

Looking Ahead

Going forward, key indicators to watch include the company’s ability to reverse the negative operating profit trend, improve return ratios such as ROE and ROCE, and sustain its recent sales momentum. Additionally, monitoring technical signals and market sentiment will be important for timing any portfolio adjustments. Given the current data as of 28 July 2026, Jeevan Scientific Technology Ltd remains a stock for investors with a moderate risk appetite who seek exposure to healthcare services microcaps with potential for recovery and growth.

Conclusion

In summary, Jeevan Scientific Technology Ltd’s 'Hold' rating by MarketsMOJO reflects a comprehensive evaluation of its current fundamentals, valuation, financial trends, and technical outlook. While the company faces structural challenges, recent operational improvements and an attractive market valuation justify a neutral stance. Investors should continue to monitor developments closely and consider this rating as part of a diversified investment strategy.

Only Rs. 9,999 - Get MojoOne + Stock of the Week for 1 Year Start at 33% Off →